Summary

Parenteral Nutrition Market Growth & Trends

The global parenteral nutrition market size is expected to reach USD 9.4 billion by 2028, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 5.9% from 2021 to 2028. The growing burden of chronic diseases, such as diabetes, cancer, and other neurological conditions, increasing deficiency of essential nutrients among critically ill patients, and the growing awareness regarding hospital-related malnutrition are some of the major factors driving the adoption of parenteral nutrition. Parenteral nutrition (PN) plays a vital role in supporting better health outcomes as malnutrition can have a serious impact on hospitalized patients. Hospitalized adults diagnosed with malnutrition have a longer length of hospital stay and higher recovery costs and are five times more likely to die compared to other adult inpatients.

The consumption of fat emulsions as part of PN has significantly increased among preterm neonates in their initial life after birth owing to their intolerance to full enteral nutrition and benefits of parenteral nutrition that provides a relatively safe means for preventing nutritional deficiency. A research article published in Eastern Mediterranean Health Journal in 2017 reported that the prevalence of malnutrition among hospitalized infants and children in various countries ranged between 6.1% and 40.9%. Intravenous lipid emulsions (ILEs) are an essential component of PN, majorly in preterm and very-low-birth infants as these formulations have revolutionized the management of infants suffering from gastrointestinal (GI) anomalies and other conditions, including intestinal failure, by providing nutritional support for intestinal growth.

An increase in accidents, a higher incidence of preterm deliveries, a high natality rate, and the presence of critically ill patients with impaired enteral route physiological functioning is expected to drive the adoption of parenteral nutrition as an alternative route of administration. Malnutrition and immune imparity numbers are the highest in Asia Pacific countries, summing up almost 62% of the world’s malnourished cases. High infection rates, the lack of awareness, and poor quality of water supply and sanitation facilities are leading to a high prevalence of malnourishment in the Asia Pacific, creating a significant demand for parenteral nutrition sources to help fulfill nutritional requirements, thereby aiding the market growth.

Parenteral Nutrition Market Report Highlights

• The market growth can be attributed to owing to the increasing adoption of PN products for fulfilling adequate nutritional requirements

• By nutrient type, the single dose amino acid solution segment dominated the market in 2020 owing to an increase in the influx of regulatory approved solutions

• North America dominated the market in 2020 owing to the rising prevalence of chronic diseases and malnutrition, an increasing number of new launches, and U.S. FDA approvals in this region

ページTOPに戻る

Table of Contents

Table of Contents

Chapter 1 Methodology and Scope
1.1 Research Process
1.2 Information Procurement
1.2.1 Purchased database:
1.2.1.1 GVR’s internal database
1.2.2 Market Formulation & Validation
1.3 Research Methodology
1.4 Research Scope and Assumptions
1.5 Research Methodology
1.5.1 Region Market: Cagr Calculation
1.5.2 Region-based Segment Share Calculation
1.6 List to Data Nutrient Type
Chapter 2 Executive Summary
2.1 Market Outlook
2.2 Segment Outlook
2.3 Competitive Insights
2.4 Parenteral Nutrition Market Snapshot
Chapter 3 Parenteral Nutrition Market Variables, Trends & Scope
3.1 Market Lineage Outlook
3.1.1 Parent Market Outlook
3.1.2 Ancillary Market Outlook
3.2 Penetration and Growth Prospect Mapping
3.3 User Perspective Analysis
3.3.1 Consumer Behavior Analysis
3.3.2 Market Influencer Analysis
3.4 Regulatory Framework
3.4.1 Reimbursement Framework
3.4.2 Standards & Compliances
3.5 Market Variable Analysis
3.5.1 Market Driver Analysis
3.5.2 Market Restraint Analysis
3.5.2 Industry Challenges
3.6 Parenteral Nutrition Market: Analysis Tools
3.6.1 Porter’s Five Forces Analysis
3.6.2 PESTEL Analysis
3.6.2 Major Deals & Strategic Alliances Analysis
3.6.2 Market Entry Strategies
3.7 Impact of COVID-19 on Parenteral Nutrition Market.
Chapter 4 Parenteral Nutrition Market: Nutrient Type Estimates & Trend Analysis
4.1 Segment Dashboard
4.2 Parenteral Nutrition Market: Nutrient Type Movement Analysis, USD Million, 2020 & 2028
4.2.1 Carbohydrates
4.2.1.1 Carbohydrates market estimates and forecasts, 2016 - 2028 (USD Million)
4.2.2 Parenteral Lipid Emulsion
4.2.2.1 Parenteral lipid emulsion market estimates and forecasts, 2016 - 2028 (USD Million)
4.2.3 Single Dose Amino Acid Solution
4.2.3.1 Single dose amino acid solution market estimates and forecasts, 2016 - 2028 (USD Million)
4.2.4 Trace Elements
4.2.4.1 Trace elements market estimates and forecasts, 2016 - 2028 (USD Million)
4.2.5 Vitamins & Minerals
4.2.5.1 Vitamins & Minerals market estimates and forecasts, 2016 - 2028 (USD Million)
Chapter 5 Parenteral Nutrition Market: Competitive Analysis
5.1 Company Market Position Analysis
5.2 Strategic Framework
Chapter 6 Parenteral Nutrition Market: Regional Estimates & Trend Analysis: By Nutrient type
6.1 Regional Market Snapshot
6.2 Parenteral Nutrition Market: Regional Movement Analysis, 2020 & 2028 (USD Million)
6.3 North America
6.3.1 North America parenteral nutrition market estimates and forecasts, 2016 - 2028 (USD Million)
6.3.2 U.S.
6.3.2.1 U.S. parenteral nutrition market estimates and forecasts, 2016 - 2028 (USD Million)
6.3.3 Canada
6.3.3.1 Canada parenteral nutrition market estimates and forecasts, 2016 - 2028 (USD Million)
6.4 Europe
6.4.1 Europe parenteral nutrition market estimates and forecasts, 2016 - 2028 (USD Million)
6.4.2 Germany
6.4.2.1 Germany parenteral nutrition market estimates and forecasts, 2016 - 2028 (USD Million)
6.4.3 U.K.
6.4.3.1 U.K. parenteral nutrition market estimates and forecasts, 2016 - 2028 (USD Million)
6.4.4 Italy
6.4.4.1 Italy parenteral nutrition market estimates and forecasts, 2016 - 2028 (USD Million)
6.4.5 Spain
6.4.5.1 Spain parenteral nutrition market estimates and forecasts, 2016 - 2028 (USD Million)
6.4.6 France
6.4.6.1 France parenteral nutrition market estimates and forecasts, 2016 - 2028 (USD Million)
6.5 Asia Pacific
6.5.1 Asia Pacific parenteral nutrition market estimates and forecasts, 2016 - 2028 (USD Million)
6.5.2 China
6.5.2.1 China parenteral nutrition market estimates and forecasts, 2016 - 2028 (USD Million)
6.5.3 India
6.5.3.1 India parenteral nutrition market estimates and forecasts, 2016 - 2028 (USD Million)
6.5.4 Japan
6.5.4.1 Japan parenteral nutrition market estimates and forecasts, 2016 - 2028 (USD Million)
6.5.5 Thailand
6.5.5.1 Thailand parenteral nutrition market estimates and forecasts, 2016 - 2028 (USD Million)
6.5.6 South Korea
6.5.6.1 South Korea parenteral nutrition market estimates and forecasts, 2016 - 2028 (USD Million)
6.7 Latin America
6.7.1 Latin America parenteral nutrition market estimates and forecasts, 2016 - 2028 (USD Million)
6.7.2 Brazil
6.7.2.1 Brazil parenteral nutrition market estimates and forecasts, 2016 - 2028 (USD Million)
6.7.3 Mexico
6.7.3.1 Mexico parenteral nutrition market estimates and forecasts, 2016 - 2028 (USD Million)
6.7.4 Argentina
6.7.4.1 Argentina parenteral nutrition market estimates and forecasts, 2016 - 2028 (USD Million)
6.7.5 Colombia
6.7.5.1 Colombia parenteral nutrition market estimates and forecasts, 2016 - 2028 (USD Million)
6.8 MEA
6.8.1 MEA parenteral nutrition market estimates and forecasts, 2016 - 2028 (USD Million)
6.8.2 South Africa
6.8.2.1 South Africa parenteral nutrition market estimates and forecasts, 2016 - 2028 (USD Million)
6.8.3 Saudi Arabia
6.8.3.1 Saudi Arabia parenteral nutrition market estimates and forecasts, 2016 - 2028 (USD Million)
6.8.4 UAE
6.8.4.1 UAE parenteral nutrition market estimates and forecasts, 2016 - 2028 (USD Million)
Chapter 7 Competitive Landscape
7.1 Company Profiles
7.1.1 B. Braun Melsungen AG
7.1.1.1 Company Overview
7.1.1.2 Financial Performance
7.1.1.3 Product Benchmarking
7.1.1.4 Strategic initiatives
7.1.2 Fresenius Kabi AG
7.1.2.1 Company Overview
7.1.2.2 Financial Performance
7.1.2.3 Product Benchmarking
7.1.2.4 Strategic Initiatives
7.1.3 Allergan
7.1.3.1 Company Overview
7.1.3.2 Financial Performance
7.1.3.3 Product Benchmarking
7.1.3.4 Strategic Initiatives
7.1.4 Grifols, S.A.
7.1.4.1 Company Overview
7.1.4.2 Financial Performance
7.1.4.3 Product Benchmarking
7.1.4.4 Strategic Initiatives
7.1.5 Pfizer, Inc.(Hospira)
7.1.5.1 Company Overview
7.1.5.2 Financial Performance
7.1.5.3 Product Benchmarking
7.1.5.4 Strategic Initiatives
7.1.6 Otsuka Pharmaceutical Factory, Inc.
7.1.6.1 Company Overview
7.1.6.2 Financial Performance
7.1.6.3 Product Benchmarking
7.1.6.4 Strategic Initiatives
7.1.7 Baxter
7.1.7.1 Company Overview
7.1.7.2 Financial Performance
7.1.7.3 Product Benchmarking
7.1.7.4 Strategic Initiatives
7.1.8 Aculife (Nirlife)
7.1.8.1 Company Overview
7.1.8.2 Financial Performance
7.1.8.3 Product Benchmarking
7.1.8.4 Strategic Initiatives
7.1.9 Sichuan Kelun Pharmaceutical Co., Ltd.
7.1.9.1 Company Overview
7.1.9.2 Financial Performance
7.1.9.3 Product Benchmarking
7.1.9.4 Strategic Initiatives
7.1.10 Vifor Pharma
7.1.10.1 Company Overview
7.1.10.2 Financial Performance
7.1.10.3 Product Benchmarking
7.1.10.4 Strategic Initiatives

List of Tables

TABLE 1 List of secondary data Nutrient Type
TABLE 2 List of Abbreviations
TABLE 3 North America parenteral nutrition market, by country, 2016 - 2028 (USD Million)
TABLE 4 North America parenteral nutrition market, by nutrient type, 2016 - 2028 (USD Million)
TABLE 5 U.S. parenteral nutrition market, by nutrient type, 2016 - 2028 (USD Million)
TABLE 6 Canada parenteral nutrition market, by nutrient type, 2016 - 2028 (USD Million)
TABLE 7 Europe parenteral nutrition market, by country, 2016 - 2028 (USD Million)
TABLE 8 Europe parenteral nutrition market, by nutrient type, 2016 - 2028 (USD Million)
TABLE 9 Germany parenteral nutrition market, by nutrient type, 2016 - 2028 (USD Million)
TABLE 10 U.K. parenteral nutrition market, by nutrient type, 2016 - 2028 (USD Million)
TABLE 11 Italy parenteral nutrition market, by nutrient type, 2016 - 2028 (USD Million)
TABLE 12 Spain parenteral nutrition market, by nutrient type, 2016 - 2028 (USD Million)
TABLE 13 France parenteral nutrition market, by nutrient type, 2016 - 2028 (USD Million)
TABLE 14 Asia Pacific parenteral nutrition market, by country, 2016 - 2028 (USD Million)
TABLE 15 Asia Pacific parenteral nutrition market, by nutrient type, 2016 - 2028 (USD Million)
TABLE 16 Japan parenteral nutrition market, by nutrient type, 2016 - 2028 (USD Million)
TABLE 17 China parenteral nutrition market, by nutrient type, 2016 - 2028 (USD Million)
TABLE 18 India parenteral nutrition market, by nutrient type, 2016 - 2028 (USD Million)
TABLE 19 Thailand parenteral nutrition market, by nutrient type, 2016 - 2028 (USD Million)
TABLE 20 South Korea parenteral nutrition market, by nutrient type, 2016 - 2028 (USD Million)
TABLE 21 Latin America parenteral nutrition market, by country, 2016 - 2028 (USD Million)
TABLE 22 Latin America parenteral nutrition market, by nutrient type, 2016 - 2028 (USD Million)
TABLE 23 Brazil parenteral nutrition market, by nutrient type, 2016 - 2028 (USD Million)
TABLE 24 Mexico parenteral nutrition market, by nutrient type, 2016 - 2028 (USD Million)
TABLE 25 Argentina parenteral nutrition market, by nutrient type, 2016 - 2028 (USD Million)
TABLE 26 Colombia parenteral nutrition market, by nutrient type, 2016 - 2028 (USD Million)
TABLE 27 MEA parenteral nutrition market, by country, 2016 - 2028 (USD Million)
TABLE 28 MEA parenteral nutrition market, by nutrient type, 2016 - 2028 (USD Million)
TABLE 29 South Africa parenteral nutrition market, by nutrient type, 2016 - 2028 (USD Million)
TABLE 30 Saudi Arabia parenteral nutrition market, by nutrient type, 2016 - 2028 (USD Million)
TABLE 31 UAE parenteral nutrition market, by nutrient type, 2016 - 2028 (USD Million)

List of Figures

FIG. 1 Market research process
FIG. 2 Information procurement
FIG. 3 Primary research pattern
FIG. 4 Market research approaches
FIG. 5 Value-chain-based sizing & forecasting
FIG. 6 QFD modeling for market share assessment
FIG. 7 Market formulation & validation
FIG. 8 Commodity Flow Analysis
FIG. 9 Volume Price Analysis
FIG. 10 Parenteral nutrition market snapshot (2020)
FIG. 11 Parenteral nutrition market segmentation
FIG. 12 Parenteral nutrition market: Strategy framework
FIG. 13 Market trends and outlook
FIG. 14 Parent market outlook
FIG. 15 Related/ancillary market outlook
FIG. 16 Penetration & growth prospect mapping
FIG. 17 Market driver relevance analysis (Current & future impact)
FIG. 18 Market restraint relevance analysis (Current & future impact)
FIG. 19 Parenteral nutrition market, nutrient type outlook: key takeaways (USD Million)
FIG. 20 Parenteral nutrition market: nutrient type movement analysis, 2020 & 2028 (USD Million)
FIG. 21 Carbohydrates market estimates and forecasts, 2016 - 2028 (USD Million)
FIG. 22 Parenteral lipid emulsion market estimates and forecasts, 2016 - 2028 (USD Million)
FIG. 23 Single dose amino acid solution market estimates and forecasts, 2016 - 2028 (USD Million)
FIG. 24 Trace elements market estimates and forecasts, 2016 - 2028 (USD Million)
FIG. 25 Vitamins & Minerals market estimates and forecasts, 2016 - 2028 (USD Million)
FIG. 26 Parenteral nutrition market, regional marketplace: Key takeaways (USD Million)
FIG. 27 Parenteral nutrition market: regional movement analysis, 2020 & 2028 (USD Million)
FIG. 28 North America market estimates and forecasts, 2016 - 2028 (USD Million)
FIG. 29 U.S. market estimates and forecasts, 2016 - 2028 (USD Million)
FIG. 30 Canada market estimates and forecasts, 2016 - 2028 (USD Million)
FIG. 31 Europe market estimates and forecasts, 2016 - 2028 (USD Million)
FIG. 32 Germany market estimates and forecasts, 2016 - 2028 (USD Million)
FIG. 33 U.K. market estimates and forecasts, 2016 - 2028 (USD Million)
FIG. 34 Italy market estimates and forecasts, 2016 - 2028 (USD Million)
FIG. 35 Spain market estimates and forecasts, 2016 - 2028 (USD Million)
FIG. 36 France market estimates and forecasts, 2016 - 2028 (USD Million)
FIG. 37 Asia Pacific market estimates and forecasts, 2016 - 2028 (USD Million)
FIG. 38 Japan market estimates and forecasts, 2016 - 2028 (USD Million)
FIG. 39 China market estimates and forecasts, 2016 - 2028 (USD Million)
FIG. 40 India market estimates and forecasts, 2016 - 2028 (USD Million)
FIG. 41 Thailand market estimates and forecasts, 2016 - 2028 (USD Million)
FIG. 42 South Korea market estimates and forecasts, 2016 - 2028 (USD Million)
FIG. 43 Latin America market estimates and forecasts, 2016 - 2028 (USD Million)
FIG. 44 Brazil market estimates and forecasts, 2016 - 2028 (USD Million)
FIG. 45 Mexico market estimates and forecasts, 2016 - 2028 (USD Million)
FIG. 46 Argentina market estimates and forecasts, 2016 - 2028 (USD Million)
FIG. 47 Colombia market estimates and forecasts, 2016 - 2028 (USD Million)
FIG. 48 MEA market estimates and forecasts, 2016 - 2028 (USD Million)
FIG. 49 South Africa market estimates and forecasts, 2016 - 2028 (USD Million)
FIG. 50 Saudi Arabia market estimates and forecasts, 2016 - 2028 (USD Million)
FIG. 51 UAE market estimates and forecasts, 2016 - 2028 (USD Million)